Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog.

Journal of Veterinary Internal Medicine
Joseph MascianaJohn Chretin

Abstract

Describe the clinical course and management of a dog that underwent hematopoietic stem cell transplantation (HSCT) for treatment of B-cell lymphoma and developed acquired circulating factor V (FV) inhibitors. An 8-year-old male castrated Briard dog diagnosed with lymphoma (IVb, B-cell) presented for allogeneic HSCT. Despite multiple platelet, fresh frozen plasma, and red blood cell transfusions prolonged recovery and clinical bleeding occurred. Circulating acquired FV inhibitors were identified and hemorrhage subsequently was managed by immunosuppression. The dog was discharged when clinical resolution of bleeding was achieved. This case report describes a dog undergoing curative intent treatment for lymphoma, and subsequently acquiring factor inhibition, and was successfully managed. Specific coagulation screening to assess for coagulation factor deficiencies or inhibitors is essential in the diagnosis and treatment of patients with refractory bleeding or only transient response to blood transfusion.

References

Mar 31, 1999·Baillière's Clinical Haematology·P Knöbl, K Lechner
Apr 28, 1999·The Journal of Laboratory and Clinical Medicine·T L Ortel
Sep 27, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Viroj Wiwanitkit
Sep 13, 2007·Thrombosis and Haemostasis·Dragana MilojkovicGhulam Mufti
Sep 13, 2007·American Journal of Hematology·Agnes LebrunMarc Michel
Aug 19, 2009·Anaesthesia·C J Morris, N Curry
Nov 6, 2010·Journal of Thrombosis and Thrombolysis·Massimo Franchini, Giuseppe Lippi
Feb 4, 2011·The American Journal of the Medical Sciences·Ravi K BobbaCarl E Freter
Dec 17, 2011·The Journal of Trauma·Sandro B RizoliHomer C Tien
Aug 1, 2009·Journal of Veterinary Emergency and Critical Care·Benjamin M O'KelleyMarjory B Brooks
Apr 16, 2015·Journal of the American Veterinary Medical Association·Steven E SuterGopalakrishnan M Venkataraman
Aug 14, 2015·Journal of Thrombosis and Haemostasis : JTH·K Donohoe, R Levine
Oct 18, 2016·Internal Medicine·Daisuke HiraiHiroshi Koyama
Jul 30, 2017·Thrombosis Research·Alexandre TheronChristine Biron-Andreani
Dec 1, 2017·Archives of Pathology & Laboratory Medicine·Nicholas J Olson, Deborah L Ornstein
Sep 30, 2018·Thrombosis Research·Tomoko Mitsuhashi, Osamu Takamiya
Nov 18, 2018·International Journal of Hematology·Hina OgawaAkitada Ichinose

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Veterinary Emergency and Critical Care
Benjamin M O'KelleyMarjory B Brooks
Archives of Pathology & Laboratory Medicine
Nicholas J Olson, Deborah L Ornstein
Nihon rinsho. Japanese journal of clinical medicine
Satomi Ueda, Shinichiro Okamoto
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Yan-hui YangRen-chi Yang
© 2021 Meta ULC. All rights reserved